Skip to main content
AXIM logo

AXIM · Axim Biotechnologies, Inc.

Track AXIM — free
$0.00 +0.00 (+5.56%) At close · Sep 4
Market Cap
$1.21M
Shares
301.96M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$39.52K +345.3%
FY2023 Revenue FY2011–FY2023
Net Income
-$8.06M -29.1%
FY2023 Net Income FY2011–FY2023
Gross Margin
0% -95.6pp
FY2019 Gross Margin FY2015–FY2019
Operating Margin
-6960.98% +45464.6pp
FY2023 Operating Margin FY2015–FY2023
Diluted EPS
-$0.04 0%
FY2023 Diluted EPS FY2019–FY2023
Operating Cash Flow
-$1.03M +49.6%
FY2023 Operating Cash Flow FY2011–FY2023

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
$92.65K $39.52K $8875 $60.46K $0 $799.48K $195.61K $47.57K $47.06K $49.14K $0 $21.67K $43.33K $10K
$0 $0 $8511 $42.86K $154.13K $50.39K $0
$0 $0 $187.1K $4716 -$107.07K -$1248 $0
0% 95.65% 9.91% -227.53% -2.54%
$90.64K $125.5K $153.7K $284.87K $426.71K $0 $2.06M $1.35M $235.58K $571.46K $0
$5.67M $4.51M $3.11M $3.16M $1.8M $3.41M
$1.88M $2.24M $4.08M $5.67M $3.41M $9.48M $505.73K
$394.45K $394.45K $394.45K $2.09M $0 $3158 $9475 $0 $10K $5472 $832
$429.65K $427.02K $426.13K $2.12M $16K $3356 $1119 $0
$2.4M $2.79M $4.66M $14.04M $4.95M $3.11M $5.22M $3.15M $3.65M $10.05M $505.73K $62.89K $58.24K $12.79K
-$2.31M -$2.75M -$4.65M -$13.97M -$4.95M -$3.11M -$5.04M -$3.15M -$3.76M -$10.05M -$505.73K
-6960.98% -52425.6% -23114.45% -388.86% -2574.53% -6619.48% -7988.83% -20451.26%
-$1.88M -$2.32M -$4.23M -$11.86M -$4.93M -$3.76M -$10.05M -$505.73K
$247.79K $234.75K $222.24K $456.06K $315.01K $275.73K $43.22K $32.52K
$1026 $675 $0 $1597 $0
$1.82M $5.31M $1.59M $2.05M $1.34M $141.91K -$1.72M -$1.02M -$2.05M $43.22K $32.52K
-$4.14M -$8.06M -$6.24M -$16.02M -$6.29M -$2.97M -$6.75M -$4.17M -$5.81M -$10.09M -$538.25K
$0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
-$4.14M -$8.06M -$6.24M -$16.03M -$6.41M -$6.45M -$6.75M -$4.17M -$5.81M -$10.09M -$582.95K -$89.22K -$14.9K -$2794
-20394.96% -70343.09% -26517.21% -806.47% -3453.05% -8761.7% -12346% -20539.22% -411.77% -34.39% -27.94%
-$6.24M -$16.03M -$6.41M -$6.45M -$6.75M -$4.17M -$7.28M
$0 $0
USD/shares -$0.02 -$0.04 -$0.04 $0.12 -$0.06 -$0.10
USD/shares -$0.02 -$0.04 -$0.04 $0.12 -$0.06 -$0.10
shares 110.39M 61.95M 57.28M 53.3M 41.73M 37.05M 33M 33M 33M 23.28M
shares 110.39M 61.95M 57.28M 53.3M 41.73M 37.05M 33M 33M 33M 23.28M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation over time computed as of each quarter's filing date

Key facts CIK 1514946 CUSIP 05463V100 Visit website Investor relations